Table 3.
Treatment Year 2 (1999 with the Exception of Maryland, 2000)
|
|
|
Treatment |
Control |
|
|
||
---|---|---|---|---|---|---|---|---|
Comparison | Site | Date | Samples | Nymphs (SD) | Samples | Nymphs (SD) | Weight | Effect size |
1 | RI | 5/26–6/1/99 | 15 | 18.9 (0.9) | 15 | 22.1 (1.5) | 7.5 | −0.17 |
2 | RI | 6/3–6/8/99 | 15 | 14.4 (0.9) | 15 | 24.4 (1.6) | 7.3 | −0.49 |
3 | RI | 6/14–6/21/99 | 15 | 13.7 (0.7) | 15 | 12.3 (0.7) | 7.5 | 0.12 |
4 | RI | 6/24–6/30/99 | 15 | 5.7 (0.3) | 15 | 20.2 (1.3) | 6.7 | −1.00 |
5 | CT | 5/17–5/20/99 | 16 | 36 (3) | 12 | 45 (3) | 6.7 | −0.48 |
6 | CT | 6/2–6/3/99 | 16 | 60 (4) | 12 | 74 (5) | 6.6 | −0.53 |
7 | CT | 6/14/99 | 16 | 83 (5) | 12 | 35 (3) | 6.7 | 0.50 |
8 | CT | 6/28/99 | 16 | 48 (2) | 12 | 54 (4) | 6.7 | −0.50 |
9 | CT | 7/12/99 | 16 | 8 (1) | 12 | 24 (2) | 6.0 | −1.09 |
10 | CT | 7/26/99 | 16 | 22 (1) | 12 | 14 (2) | 6.8 | 0.13 |
11 | NY | 5/12–6/25/99 | 26 | 75.0 (2.9) | 35 | 65.1 (1.6) | 14.6 | 0.45 |
12 | NY | 7/7–8/18/99 | 24 | 42.9 (1.3) | 24 | 28.0 (1.3) | 11.7 | 0.48 |
13 | NJ | 5/26/99 | 25 | 41 (2) | 20 | 120 (8) | 10.3 | −0.78 |
14 | NJ | 6/1/99 | 25 | 43 (3) | 20 | 110 (6) | 10.3 | −0.81 |
15 | NJ | 6/8/99 | 25 | 73 (3) | 20 | 67 (4) | 11.1 | −0.10 |
16 | NJ | 6/15/99 | 25 | 80 (4) | 20 | 174 (9) | 10.4 | −0.77 |
17 | MD | 6/9/00 | 15 | 108 (5) | 15 | 365.0 (21.1) | 6.5 | −1.08 |
18 | MD | 6/20/00 | 15 | 102 (6) | 15 | 232.1 (9.3) | 6.5 | −1.08 |
19 | MD | 6/27/00 | 15 | 40 (3) | 15 | 196.4 (7.8) | 5.5 | −1.71 |
20 | MD | 6/30/00 | 15 | 34 (2) | 15 | 160.6 (6.4) | 5.4 | −1.75 |
SD, standard deviation.